<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Anderson EMS Pocket Medic</title>
    <link rel="icon" href="../favicon.ico" type="image/png" />
    <link rel="stylesheet" href="../Cardiac.css" />
    <link rel="stylesheet" href="CHF.css" />
  </head>
  <body>
    <a href="../../../index.html" class="header-link">
      <div class="header">
        <h1>Anderson EMS Pocket Medic</h1>
      </div>
    </a>

    <div class="MainBody">
      <h2>CHF<br />Pulmonary Edema</h2>

      <div class="InitialBody">
        <table class="StartTable">
          <thead>
            <tr>
              <th>History</th>
              <th>Signs and Symptoms</th>
              <th>Differential</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>
                • Congestive Heart Failure (CHF)<br /><br />
                <span class="Indention">
                  Use of diuretics and compliance<br />

                  Weight gain<br />
                  Leg swelling<br />
                  Orthopnea </span
                ><br />

                • Past Medical History<br /><br />
                • Medications (Digoxin, Lasix)<br /><br />
                • Erectile Dysfunction Medication<br /><br />
                • Cardiac History (prior MI)
              </td>
              <td>
                • Respiratory distress (crackles / rales)<br /><br />
                • Lower extremity edema<br /><br />
                • Orthopnea<br /><br />
                • Jugular Vein Distention (JVD)<br /><br />
                • Pink, frothy sputum<br /><br />
                • Diaphoresis<br /><br />
                • Hypotension, shock<br /><br />
                • Chest pain
              </td>
              <td>
                • Myocardial Infarction (MI)<br /><br />
                • CHF<br /><br />
                • Asthma / COPD<br /><br />
                • Anaphylaxis<br /><br />
                • Aspiration<br /><br />
                • Pleural effusion<br /><br />
                • Pneumonia<br /><br />
                • Pulmonary Embolus (PE)<br /><br />

                • Pericardial tamponade <br /><br />
                • Toxic exposure
              </td>
            </tr>
          </tbody>
        </table>
        <h3 class="AllLevels">EMR</h3>
        <p>
          1.
          <a
            href="../../General/UniversalSources/Universal.html"
            class="working-link"
            title="Unviersal Patient Care SOG"
            >UNIVERSAL PATIENT CARE</a
          >.
        </p>
        <h3 class="EMT">EMT</h3>
        <p>
          1. Continue <strong>EMR TREATMENT</strong>.<br /><br />
          2. Obtain 12-Lead ECG and transmit to receiving facility (if
          available).<br /><br />
          3. If dyspnea is present, apply
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a
          >@ <strong>5-10cm H2O</strong>. Contact medical control if
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a>
          setting &gt;10cm H2O is required.<br /><br />
          4. Relay information to incoming ambulance and/or call for intercept
          per
          <a
            href="../../General/InterceptCriteriaSources/Intercept.html"
            class="working-link"
            title="Intercept Criteria SOG"
            >INTERCEPT CRITERIA</a
          >.
        </p>
        <h3 class="PARAMEDIC">Paramedic/PHRN</h3>
        <p>
          1. <strong>EMR/EMT TREATEMENT</strong>.**12 Lead ECG transmission is
          discretionary, transmit when appropriate.<br /><br />

          2. Establish IV access.<br /><br />

          3. If SBP &gt; 90 mmHg or MAP &gt; 65 mmHg:<br /><br />
          <span class="Indention">
            a. Administer
            <a
              href="../../../DrugMaterial/NitroglycerinFolder/nitroglycerin.html"
              class="working-link"
              title="Nitroglycerin Med Page"
              >NITROGLYCERIN</a
            >
            <strong>0.4 mg SL x1</strong>.(<i
              >If SBP &gt;180mmHg
              <a
                href="../../../DrugMaterial/NitroglycerinFolder/nitroglycerin.html"
                class="working-link"
                title="Nitroglycerin Med Page"
                >NITROGLYCERIN</a
              >
              <strong>0.4 mg SL x2</strong></i
            >)<br /><br />

            b. Consider additional
            <a
              href="../../../DrugMaterial/NitroglycerinFolder/nitroglycerin.html"
              class="working-link"
              title="Nitroglycerin Med Page"
              >NITROGLYCERIN</a
            >
            <strong>0.4 mg SL every 3-5 minutes</strong>.<br /><br />
            <span class="Indention">
              • If
              <a href="#" class="placeholder-link" title="Page coming soon"
                >CPAP</a
              >
              is already applied, do not remove
              <a href="#" class="placeholder-link" title="Page coming soon"
                >CPAP</a
              >
              to administer NITRO. </span
            ><br />

            c. In lieu of additional SL doses, the provider may apply
            <a
              href="../../../DrugMaterial/NitroglycerinFolder/nitroglycerin.html"
              class="working-link"
              title="Nitroglycerin Med Page"
              >NITROGLYCERIN PASTE</a
            >, <strong>1 inch</strong>, to patient’s chest (<i
              >remove if SBP &lt; 100 mmHg or MAP &lt; 70 mmHg</i
            >). </span
          ><br />

          4. If wheezing is present and if EtCO2 waveform supports concurrent
          bronchospasm refer to
          <a
            href="../../AdultMedical/AsthmaSources/Asthma.html"
            class="working-link"
            title="ASTHMA COPD SOG"
            >BRONCHOSPASM / ASTHMA / COPD</a
          >
          Protocol.<br /><br />

          5. If signs of Cardiogenic Shock, consider
          <a
            href="../../../DrugMaterial/NorepinephrineFolder/norepinephrine.html"
            class="working-link"
            title="Norepienephrine Med Page"
            >NOREPINEPHRINE</a
          >
          <strong>2-30 mcg/min</strong> (if available, with IV pump) titrated to
          a SBP of 90-100 mmHg or MAP &gt; 65 mmHg<br /><br />
          <span class="Indention">
            <u>Alternative medication:</u><br /><br />
            <a
              href="../../../DrugMaterial/Epi100000Folder/epi100000.html"
              class="working-link"
              title="Epi 1:100,000 Med Page"
              >PUSH DOSE EPINEPHRINE</a
            >
            <strong>1 mL (10 mcg) IV/IO</strong> every 2-5 minutes to maintain
            SBP of 90-100 mmHg or MAP &gt; 65 mmHg.<br /><br />
            <span class="Indention">
              a. Mix 1 mL of Epinephrine <strong>1mg/10mL</strong>(1:10,000)
              with 9 mL of Normal Saline in a 10 mL syringe resulting in a
              concentration of 10 mcg/mL. </span
            ><br />
            <a
              href="../../../DrugMaterial/DopamineFolder/dopamine.html"
              class="working-link"
              title="Dopamine Med Page"
              >DOPAMINE</a
            >
            at 5-20 mcg/kg/min titrated to a SBP of 90-100 mmHg or MAP &gt; 65
            mmHg.
          </span>
        </p>
        <p>
          <strong>PEARLS</strong><br /><br />
          • Consider Myocardial Infarction (MI) in all these patients.<br /><br />
          • Allow patient to remain in position of comfort - patients may
          decompensate if forced to lie down.<br /><br />
          • The use of nitrates should be avoided in any patient who has used
          erectile dysfunction medications within the past 48 hours due to
          possible severe hypotension.<br /><br />
          <span class="Indention">
            -Examples: Viagra® / sildenafil, Levitra® / vardenafil, Cialias® /
            tadalafil</span
          ><br />

          • Administer nitrates with extreme caution, if at all, to patients
          with inferior-wall STEMI or suspected right ventricular (RV)
          involvement because these patients require adequate RV preload.<br /><br />
          • Use of Furosemide (Lasix®) is not recommended in the prehospital
          setting. Pulmonary edema is more commonly a problem of volume
          distribution than overload, so administration of Furosemide provides
          no immediate benefit for most patients. Misdiagnosis of CHF and
          subsequent inducement of inappropriate diuresis can lead to increased
          morbidity and mortality in patients.<br /><br />
          • <strong><u>Cardiogenic Shock</u></strong
          >: Heart failure, MI, Cardiomyopathy, Myocardial contusion, Ruptured
          ventrical/ septum/valve, Toxins.
        </p>

        <table class="EndTable">
          <thead>
            <tr>
              <th><strong>KEY DOCUMENTATION ELEMENTS </strong></th>
              <th><strong>PERTINENT ASSESSMENT FINDINGS </strong></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>
                • Vital signs<br /><br />
                • Oxygen saturation<br /><br />
                • Time of intervention<br /><br />
                • Response to interventions
              </td>
              <td>
                • Full vital signs<br /><br />
                • Respiratory distress<br /><br />
                • Breath sounds (crackles / rales)<br /><br />
                • Edema<br /><br />
                • JVD
              </td>
            </tr>
          </tbody>
        </table>
        <table class="QMTable">
          <tr>
            <td><strong>QUALITY METRICS</strong><br /><br /></td>
          </tr>
          <tr>
            <td>
              • Time to initiation of CPAP<br /><br />
              • Assessment / auscultation of lung sounds before and after each
              intervention
            </td>
          </tr>
        </table>
      </div>
    </div>
    <script src="https://code.jquery.com/jquery-3.7.1.min.js"></script>
    <script src="CHF.js"></script>
  </body>
  <footer class="footer">
    <p>&copy; 2025 LukiSoft. All rights reserved.</p>
  </footer>
</html>
